Malignant Peripheral Nerve Sheath Tumor
Oncology
Prevalence
5.0 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| selumetinib | GH Research PLC (GHRS) |
Frequently asked questions
How many drugs are in development for Malignant Peripheral Nerve Sheath Tumor?
BioSniper tracks 1 drug in development for Malignant Peripheral Nerve Sheath Tumor across 1 company.
How many clinical trials target Malignant Peripheral Nerve Sheath Tumor?
There are 1 clinical trial targeting Malignant Peripheral Nerve Sheath Tumor tracked by BioSniper.
What is the prevalence of Malignant Peripheral Nerve Sheath Tumor?
The estimated prevalence of Malignant Peripheral Nerve Sheath Tumor is approximately 5.0 per 100,000 population.
Deep-dive into Malignant Peripheral Nerve Sheath Tumor
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis